The underlying mechanism may be that sema3A breaks the Pak1/RAS activation circle; restores the sensitivity of mast cells to apoptosis inducers, which reduces mast cells in the intestine; and, thus, contributes to alleviating FA symptoms. The gene discussed is SEMA3A; the disease is Friedreich ataxia.